StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5
Publishing Date
2020 - 12 - 01
172
2020 - 11 - 30
3
2020 - 11 - 23
5
2020 - 11 - 19
4
2020 - 11 - 17
5
2020 - 11 - 16
3
2020 - 11 - 12
4
2020 - 11 - 10
4
2020 - 11 - 04
3
2020 - 11 - 02
5
2020 - 10 - 21
8
2020 - 10 - 19
4
2020 - 10 - 14
4
2020 - 10 - 09
3
2020 - 10 - 08
3
2020 - 10 - 06
3
2020 - 09 - 15
3
2020 - 09 - 14
4
2020 - 09 - 03
3
2020 - 08 - 31
5
2020 - 08 - 24
3
2020 - 08 - 20
3
2020 - 08 - 17
4
2020 - 08 - 13
3
2020 - 08 - 11
3
2020 - 08 - 06
3
2020 - 08 - 05
3
2020 - 08 - 03
4
2020 - 07 - 29
3
2020 - 07 - 23
3
2020 - 07 - 21
4
2020 - 07 - 14
3
2020 - 07 - 08
2
2020 - 07 - 07
2
2020 - 07 - 02
2
2020 - 06 - 29
3
2020 - 06 - 25
2
2020 - 06 - 23
3
2020 - 06 - 22
5
2020 - 06 - 19
2
2020 - 06 - 18
2
2020 - 06 - 11
3
2020 - 06 - 09
2
2020 - 06 - 08
2
2020 - 06 - 02
2
2020 - 06 - 01
2
2020 - 05 - 29
2
2020 - 05 - 28
2
2020 - 05 - 27
2
2020 - 05 - 22
3
2020 - 05 - 14
2
2020 - 05 - 07
2
2020 - 04 - 30
2
2020 - 04 - 23
2
2020 - 04 - 20
2
2020 - 04 - 15
2
2020 - 04 - 01
2
2020 - 03 - 16
2
2020 - 03 - 02
2
2019 - 07 - 24
2
Sector
Health technology
5
Tags
Calendar of events
1
Cancer
1
Company announcement
3
Cystic fibrosis
1
Drug
1
Fda
1
Fda acceptance
1
Fibrosis
1
New drug
1
Nivolumab
1
Phase 1
1
Phase 2
1
Phase 2b
1
Phase 3
2
Press releases
1
Prostate cancer
1
Results
1
Therapy
1
Treatment
2
Entities
Corbus pharmaceuticals holdings, inc.
1
Dynavax technologies corporation
1
Myovant sciences ltd.
2
Onconova therapeutics, inc.
1
Symbols
CRBP
1
DVAX
1
MYOV
2
ONTX
1
Exchanges
Nasdaq
3
Nyse
2
Crawled Date
2021 - 02 - 04
1
2020 - 12 - 26
1
2020 - 12 - 23
1
2020 - 12 - 01
5
Crawled Time
22:15
4
22:16
1
Source
www.globenewswire.com
5
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2020 - 06 - 22
crawled date :
2020 - 12 - 01
save search
Dynavax to Present at the H.C. Wainwright Virtual Fireside Chat Series
Published:
2020-06-22
(Crawled : 22:16)
- globenewswire.com
DVAX
|
$11.78
3.88%
3.74%
9.3M
|
Health Technology
|
73.53%
|
O:
2.22%
H:
2.54%
C:
-0.37%
Onconova Therapeutics Announces the Initiation of a Phase 1/2a Study of Rigosertib plus Nivolumab for the Treatment of KRAS+ Lung Adenocarcinoma
Published:
2020-06-22
(Crawled : 22:15)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
72.98%
|
O:
3.79%
H:
6.33%
C:
2.38%
treatment
phase 3
phase 1
phase 2
nivolumab
Corbus Pharmaceuticals Reports Last Subject Visit in Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
Published:
2020-06-22
(Crawled : 22:15)
- globenewswire.com
CRBP
|
$39.12
7.09%
6.62%
280K
|
Health Technology
|
435.42%
|
O:
1.43%
H:
2.25%
C:
0.64%
treatment
phase 2b
fibrosis
cystic fibrosis
Myovant Sciences Announces Priority Review and FDA Acceptance of New Drug Application for Once-Daily, Oral Relugolix for Advanced Prostate Cancer
Published:
2020-06-22
(Crawled : 22:15)
- globenewswire.com
MYOV
|
$26.98
-0.04%
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
cancer
fda
drug
prostate cancer
fda acceptance
new drug
Myovant Sciences to Host Webcast and Conference Call at 8:30 am Eastern Time Tuesday, June 23 to Discuss Results from Phase 3 SPIRIT 1 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Endometriosis
Published:
2020-06-22
(Crawled : 22:15)
- globenewswire.com
MYOV
|
$26.98
-0.04%
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
therapy
results
phase 3
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.